Can people in China use better medicine?

In recent years, food safety, high drug prices and difficulty in seeing a doctor have been criticized by the people. Can the pharmaceutical industry in China improve product quality and medical service level to meet the growing health needs of the people?

On March 201July 17, the State Food and Drug Administration (CFDA) issued the "Decision on Adjusting the Registration Management of Imported Drugs (Draft for Comment)", which lowered the policy threshold for foreign new drugs to enter China and achieved the synchronization of China's new drug research and development and listing with the world.

The industry is still discussing how to deal with the "wolf coming" (I'm worried that with the encouragement of the New Deal, multinational companies will speed up their entry into China, occupying limited clinical trial resources, which is not conducive to the innovation of domestic local pharmaceutical companies). On May 1 1-12, CFDA issued four documents (draft for comments) beginning with "encouragement" in two days. This is the biggest time to encourage innovation since CFDA 2065 438+05 started the reform, which touches many aspects of drug innovation, including slow review and approval, low level of clinical trials and insufficient resources.